Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.

Anticancer research - 1 Sept 2016

Chang Wen-Shin, Liao Cheng-Hsi, Tsai Chia-Wen, Hu Pei-Shin, Wu Hsi-Chin, Hsu Shih-Wei, Hsiao Chieh-Lun, Hsu Chang-Hsien, Hung Yi-Wen, Bau DA-Tian

Abstract excerpt

AIM: Bladder cancer is the sixth most common cancer worldwide and its incidence is particularly high in many developed regions including southwestern Taiwan. However, the genetic contribution to the etiology of bladder cancer is not well-understood. The aim of this study was to evaluate the association of the enhancer of zeste homolog 2 (EZH2) genotypes with Taiwan bladder cancer risk. MATERIALS AND METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcohol Drinking
Share to Cell Cycle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Down-Regulation

Share to Enhancer of Zeste Homolog 2 Protein

Share to Smoking

Share to Taiwan

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 27630289
DOI: 10.21873/anticanres.10997

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.PMID 27630289Read ↗

EZH2 in Bladder Cancer, a Promising Therapeutic TargetSemantic proximity Read ↗

Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features.Semantic proximity Read ↗

Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility.Semantic proximity Read ↗

Bladder cancer epidemiology and genetic susceptibilitySemantic proximity Read ↗

Association of EZH2 Genotypes With Oral Cancer Risk.Semantic proximity Read ↗

Associations of cyclooxygenase 2 polymorphic genotypes with bladder cancer risk in Taiwan.Semantic proximity Read ↗

Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population.Semantic proximity Read ↗

National And Subnational Incidence of Bladder Cancer In Iran: Results of The Iranian National Population-Based Cancer Registry Over A 12-Year PeriodSemantic proximity Read ↗

Role of EZH2 polymorphisms in esophageal squamous cell carcinoma risk in Han Chinese population.Semantic proximity Read ↗

Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.Semantic proximity Read ↗

EZH2 genetic variants affect risk of gastric cancer in the Chinese Han population.Semantic proximity Read ↗

E-cadherin gene promoter hypermethylation may contribute to the risk of bladder cancer among Asian populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.